SCHEMBL6264458

SCHEMBL6264458

CCN(CC)CC.Oc1ccccc1N(CCCl)CCCl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
HSD17B10 Q99714 2/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
NFKB1 P19838 1/20 0.41
CYP2C19 P33261 1/20 0.41
MAPT P10636 1/20 0.41
LMNA P02545 1/20 0.41
BLM P54132 1/20 0.41
HTR1A P08908 3/20 0.38
CHEK1 O14757 1/20 0.36
PIM1 P11309 1/20 0.36
IDO1 P14902 1/20 0.36
LTK P29376 1/20 0.36
LIMK1 P53667 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
EGFR P00533 2/20 0.35
ERBB2 P04626 2/20 0.35
POLB P06746 1/20 0.35
CA1 P00915 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1061884 0.89 CA2 (0.38) HSD17B10NFKB1MAPTLMNABLM
SCHEMBL11580920 0.79 HTR1A (0.34) CYP1A2HSD17B10CYP2D6TSHRNFKB1
SCHEMBL1837510 0.77 HTR1A (0.48) HSD17B10TSHRNFKB1MAPTLMNA
SCHEMBL387883 0.77 ALDH1A1 (0.42) HSD17B10TSHRNFKB1MAPTLMNA
SCHEMBL10333062 0.77 ALDH1A1 (0.42) HSD17B10TSHRNFKB1MAPTLMNA
Catechol SCHEMBL29648961 0.74 KDM4E (0.56) HSD17B10TSHRNFKB1MAPTLMNA
Catechol SCHEMBL27915952 0.74 KDM4E (0.56) HSD17B10TSHRNFKB1MAPTLMNA
SCHEMBL6880657 0.74 HTR1A (0.46) TSHRHTR1ACA1CA2
SCHEMBL30525531 0.74 LMNA (0.47) TSHRMAPTLMNAHTR1APOLB
SCHEMBL1836555 0.74 LMNA (0.47) TSHRMAPTLMNAHTR1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0944583-B1 NOVEL COMPOUNDS USEFUL AS THERAPEUTIC AGENTS AND ASSAY REAGENTS RILEY PATRICK ANTHONY (GB) 2005-11-16 EP disclosed
US-6573284-B1 Pro-drugs and assay reagents are provided which are useful as therapeutic agents especially for delivery and targetting therapeutically active agents to melanoma cells. The pro-drugs and assay reagents are substrates for tyrosinase PHAIRSON MEDICAL LTD (GB) 2003-06-03 US disclosed